EPCAM and adenocarcinoma: In conclusion, a combination of at least two positive mesothelial (calretinin, CK 5/6, WT-1 and D2-40) and at least two negative adenocarcinoma immunohistochemical markers (TTF1, CEA and Ber-EP4) should be used in the differential diagnosis of MPM [59].